A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a ...

The 10-minute procedure identified signs of acute myeloid leukaemia (AML) returning in patients before it showed in blood ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

The trial’s primary goal is to assess the tolerability and safety and to establish the recommended Phase II dose.

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping ...

Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...